Stock EPMT PT ENSEVAL PUTERA MEGATRADING TBK.
Add to a list
To use this feature you must be a member
Log inSign up

Financials PT Enseval Putera Megatrading Tbk.

Equities

EPMT

ID1000096506

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
2,320 IDR 0.00% Intraday chart for PT Enseval Putera Megatrading Tbk. -0.43% -10.42%
28/03 PT Enseval Putera Megatrading Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PT Enseval Putera Megatrading Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 56,88,144 55,52,712 57,15,230 73,13,328 74,48,760 70,15,378
Enterprise Value (EV) 1 42,61,178 43,75,026 39,49,573 57,58,312 65,79,735 64,69,271
P/E ratio 8.71 x 9.56 x 8.4 x 8.63 x 8.79 x 10.2 x
Yield 4.29% 4.39% 9.48% 7.59% 7.45% -
Capitalization / Revenue 0.28 x 0.25 x 0.25 x 0.28 x 0.27 x 0.25 x
EV / Revenue 0.21 x 0.2 x 0.18 x 0.22 x 0.23 x 0.23 x
EV / EBITDA 4.43 x 5 x 4.36 x 4.86 x 5.26 x 6.16 x
EV / FCF 10.9 x -38.9 x 5.86 x 38.3 x -30.3 x 40.4 x
FCF Yield 9.2% -2.57% 17.1% 2.61% -3.3% 2.47%
Price to Book 0.98 x 0.91 x 0.87 x 1.07 x 1.05 x 0.97 x
Nbr of stocks (in thousands) 27,08,640 27,08,640 27,08,640 27,08,640 27,08,640 27,08,640
Reference price 2 2,100 2,050 2,110 2,700 2,750 2,590
Announcement Date 29/03/19 03/04/20 29/03/21 31/03/22 28/03/23 28/03/24
1IDR in Million2IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,06,04,487 2,22,26,912 2,25,45,419 2,56,73,757 2,80,27,488 2,85,07,873
EBITDA 1 9,62,103 8,75,467 9,04,943 11,85,835 12,51,054 10,50,294
EBIT 1 8,34,841 7,47,361 7,67,386 10,34,226 10,94,573 8,94,749
Operating Margin 4.05% 3.36% 3.4% 4.03% 3.91% 3.14%
Earnings before Tax (EBT) 1 8,79,481 8,13,103 8,82,740 10,91,263 11,01,140 8,92,425
Net income 1 6,53,064 5,80,630 6,80,598 8,47,881 8,47,533 6,88,499
Net margin 3.17% 2.61% 3.02% 3.3% 3.02% 2.42%
EPS 2 241.1 214.4 251.3 313.0 312.9 254.2
Free Cash Flow 1 3,92,045 -1,12,331 6,73,874 1,50,176 -2,17,420 1,59,991
FCF margin 1.9% -0.51% 2.99% 0.58% -0.78% 0.56%
FCF Conversion (EBITDA) 40.75% - 74.47% 12.66% - 15.23%
FCF Conversion (Net income) 60.03% - 99.01% 17.71% - 23.24%
Dividend per Share 2 90.00 90.00 200.0 205.0 205.0 -
Announcement Date 29/03/19 03/04/20 29/03/21 31/03/22 28/03/23 28/03/24
1IDR in Million2IDR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 14,26,966 11,77,686 17,65,657 15,55,016 8,69,025 5,46,107
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 3,92,045 -1,12,331 6,73,874 1,50,176 -2,17,420 1,59,991
ROE (net income / shareholders' equity) 12% 9.75% 10.7% 12.6% 12.1% 9.54%
ROA (Net income/ Total Assets) 6.63% 5.49% 5.35% 6.83% 6.8% 5.24%
Assets 1 98,55,787 1,05,83,462 1,27,12,427 1,24,23,167 1,24,70,870 1,31,48,068
Book Value Per Share 2 2,136 2,262 2,415 2,522 2,626 2,676
Cash Flow per Share 2 466.0 384.0 598.0 489.0 365.0 253.0
Capex 1 1,21,349 3,07,742 2,01,029 1,07,175 1,11,985 1,69,561
Capex / Sales 0.59% 1.38% 0.89% 0.42% 0.4% 0.59%
Announcement Date 29/03/19 03/04/20 29/03/21 31/03/22 28/03/23 28/03/24
1IDR in Million2IDR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PT ENSEVAL PUTERA MEGATRADING TBK. Stock PT Enseval Putera Megatrading Tbk.
-10.42% 387M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EPMT Stock
  4. Financials PT Enseval Putera Megatrading Tbk.